Responding to the British Lung Foundation economic study ‘Estimating the Economic Burden of Respiratory Illness in the UK’ which highlights that lung disease costs the UK £11 billion each year, Dr Lisa Davies, Consultant Respiratory Physician and Chair of the British Thoracic Society’s Board of Trustees, said:
'Despite being the UK's third biggest killer, lung disease is still not a Government strategic priority. This cannot continue. We have a committed workforce, world-leading research and clinical guidelines, some highly cost-effective treatments and strong examples of integrated care. But we are now facing a critical phase where we urgently need national political leadership and an overarching strategy to address the growing health and economic burden respiratory disease places on the NHS and society.’
Read the report here: https://www.blf.org.uk/what-we-do/our-research/economic-burden
Note to Editors:
The British Thoracic Society (BTS) is the UK’s professional body of respiratory specialists.
The Society seeks to improve standards of care for people who have respiratory diseases and to support and develop those who provide that care. A registered charity, it has over 3,000 members including doctors, nurses, respiratory physiotherapists, scientists and other professionals with a respiratory interest.